FindTrial
Sign In

Are intrinsic defects of the stem cell compartment responsible for the peripheral pancytopenia post-transplantation.

Are intrinsic defects of the stem cell compartment responsible for the peripheral pancytopenia post-transplantation. - ASCT; pancytopenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29955
Enrollment
Unknown
Registered
2006-09-14
Start date
2007-02-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autologous stem cell transplantation

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ASCT

Exclusion criteria

Exclusion criteria: Persistent disease activity in the bone marrow.

Design outcomes

Primary

MeasureTime frame
- In-vitro culture assay of CD34+ cells. - Phenotypic characterization of the CD34+ cell population. - Micro-array analysis of CD34+ cells. - FLT-PET—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)